design and synthesis of pyrrolo[2,1-a]isoquinoline-based derivatives as new cytotoxic agents

Authors

afshin zarghi shahid beheshti univ. med. sci.

samaneh kakhki 1department of pharmaceutical chemistry, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran 2torbat heydarieh university of medical sciences, torbat heydarieh, iran

sorayya shahosseini department of pharmaceutical chemistry, school of pharmacy, shahid beheshti university of medical sciences, tehran, iran

abstract

a new series of anti-cancer agents based on 1,2-diaryl-5,6-dihydropyrrolo[2,1-a]isoquinoline scaffold containing n,n-diethylamino ethoxy, piperidinyl ethoxy or morpholinyl ethoxy group at the para position of the c-2 phenyl ring were synthesized and their cytotoxic activities were assessed against several human cancer cell lines including mcf-7 (er positive breast cancer cell), mda-mb231 (er-negative breast cancer cell), t47d (human ductal breast epithelial tumor cell line), a549 (adenocarcinomic human alveolar basal epithelial cells), and hela (human cervix adenocarcinoma cells) using mtt assay. based on results, compounds, 1-(4-(2-(piperidin-1-yl)ethoxy)phenyl)-5,6-dihydro-8,9-dimethoxy-2-phenylpyrrolo[2,1-a]isoquinoline (6a) and 2-(4-(5,6-dihydro-8,9-dimethoxy-2-phenylpyrrolo[2,1-a] isoquinolin-1-yl)phenoxy)-n,n-diethylethanamine (6c) were the most potent cytotoxic compounds and more toxic than the reference compound against t47d cell line, while all the compounds had satisfactory activity against hela cell line with mean ic50 values ranging from 1.93 to 33.84 µm.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Design and Synthesis of Pyrrolo[2,1-a]Isoquinoline-Based Derivatives as New Cytotoxic Agents

A new series of anti-cancer agents based on 1,2-diaryl-5,6-dihydropyrrolo[2,1-a]isoquinoline scaffold containing N,N-diethylamino‌ethoxy, piperidinyl‌ethoxy or morpholinyl‌ethoxy group at the para position of the C-2 phenyl ring were synthesized and their cytotoxic activities were assessed against several human cancer cell lines including MCF-7 (ER positive breast cancer cell), MDA-MB231 (ER-ne...

full text

Design and Synthesis of Pyrrolo[2,1-a]Isoquinoline-Based Derivatives as New Cytotoxic Agents

A new series of anti-cancer agents based on 1,2-diaryl-5,6-dihydropyrrolo[2,1-a]isoquinoline scaffold containing N,N-diethylamino‌ethoxy, piperidinyl‌ethoxy or morpholinyl‌ethoxy group at the para position of the C-2 phenyl ring were synthesized and their cytotoxic activities were assessed against several human cancer cell lines including MCF-7 (ER positive breast cancer cell), MDA-MB231 (ER-ne...

full text

Design and Synthesis of Pyrrolo[2,1-a]Isoquinoline-Based Derivatives as New Cytotoxic Agents

A new series of anti-cancer agents based on 1,2-diaryl-5,6-dihydropyrrolo[2,1-a]isoquinoline scaffold containing N,N-diethylamino-ethoxy, piperidinyl-ethoxy or morpholinyl-ethoxy group at the para position of the C-2 phenyl ring were synthesized and their cytotoxic activities were assessed against several human cancer cell lines including MCF-7 (ER positive breast cancer cell), MDA-MB231 (ER-ne...

full text

Synthesis of some new tetrahydropyrimidine derivatives as possible antibacterial agents

Heterocyclic compounds containing a pyrimidine nucleus are of special interests due to their applications in medicinal chemistry as they are the basic skeleton of several bioactive compounds such as antifungal, antibacterial, antitumor and antitubercular. As a part of our research in the synthesis of pyrimidine derivatives containing biological activities, some new tetrahydropyrimidine derivati...

full text

My Resources

Save resource for easier access later


Journal title:
the iranian journal of pharmaceutical research

جلد ۱۵، شماره ۴، صفحات ۷۴۳-۷۵۱

Keywords
[ ' s y n t h e s i s ' , ' d i h y d r o p y r r o l o [ 2 ' , 1 , ' a ] i s o q u i n o l i n e s ' , ' c y t o t o x i c a c t i v i t y ' , ' m t t ' , ' d o c k i n g s t u d y ' ]

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023